1. Abu-Hadid MM, Bankert RB, Mayers GL. Antigenspecific drug-targeting used to manipulate an immune response in vivo. Proc Natl Acad Sci USA 1987; 84: 7232–7236.
2. Abuchowski A, Kazo GM, Verhoest Jr CR, Van Es T, et al. Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparagninase conjugates. Cancer Biochem Biophys 1984; 7: 175–186.
3. Basham TY, Palladino MA, Badger CC, et al. Comparison of combinations of interferons with tumor specific and nonspecific monoclonal antibodies as therapy for murine B- and T-cell lymphomas. Cancer Res 1988; 48: 4196–4200.
4. Benjamin RJ, Waldmann H. Induction of tolerance by monoclonal antibody therapy. Nature 1986; 320:449–451.
5. Bernhard MT, Foon KA, Oeltmann TN, et al. Guinea pig line 10 hepatocarcinoma model: characterization of monoclonal antibody and in vivo effect of unconjugated antibody and antibody conjugated to diphtheria toxin A chain. Cancer Res 1983; 43:4420–4428.